Indutrade Ab · OMXSTO:INDT
Indutrade Ab — Q2 2025 Earnings Presentation
17 slides from Indutrade Ab's earnings presentation, Jul 15, 2025
Slide 1: Q2 Report 2025
An entrepreneurial world where people make the difference Bo Annvik, President and CEO Q2 Report 2025 Patrik Johnson, CFO 15 July 2025
Slide 2: Highlights second quarter 2025
Highlights second quarter 2025 ▪ Stable order intake – organically unchanged, despite fewer working days and general market uncertainty. Net Sales ‒ Good demand from customers within the energy sector ‒ Stable and high aggregated demand from customers within medical technology and pharmaceutical 8.1
Slide 3: Strengthened order book but lower sales
Strengthened order book but lower sales Order intake Net Sales MSEK MSEK 9,000 30% 9,000 30% 8,000 25% 8,000 25% 20% 20% 7,000 7,000 15% 15% 6,000 6,000 10% 10% 5,000 5,000 5% 5% 4,000 4,000 0% 0% 3,000 -5% 3,000 -5% 2,000 -10% 2,000 -10% 2020 2021 2022 2023 2024 2025 2020 2021 2022 2023 2024 2025 Q
Slide 4: Organic sales development Q2 – major countries
Organic sales development Q2 – major countries Nordics Rest of Europe Rest of the world Sweden Benelux North America Denmark UK/Ireland Asia Finland Germany Norway Switzerland & Austria Total Nordics Total Rest of Europe Total Rest of the world 4
Slide 5: Declining sales impacting EBITA
Declining sales impacting EBITA EBITA & EBITA margin Quarterly growth MSEK Q growth 1,400 16% 15% 1,200 15% 10% 1,000 14% 5% 4% 13% 800 0% 12% 0% 600 11% 400 -5% -3% 10% 200 9% -10% 0 8% -15% -12% 2020 2021 2022 2023 2024 2025 Organic Acquisitions Divestments Currency Q EBITA Q EBITA margin Q2-25 MA
Slide 6: Net Sales by Business Area
Net Sales by Business Area Total growth: -2% -4% -4% -4% -10% ▪ All business areas had a negative organic sales development, mainly due to lower 10.0% backlog and strong references. 8.0% 6.0% ▪ Very strong sales for a few Scandinavian companies within Life Science same period 4.0% last year. Q organ
Slide 7: EBITA margin by Business Area
EBITA margin by Business Area EBITA margin development ▪ Stable, high gross margin of 35.3% (35.4). ▪ Organic expenses slightly lower than Q1 20% 2025 and unchanged from last year. 16.7% 15.1% ▪ EBITA margin declined in all business areas – 14.4% 15% 13.6% organic sales development the main driver.
Slide 8: Acquisitions 2025
Acquisitions 2025 # Company Country Business area Annual sales 1. Germany Industrial & Engineering 150 MSEK 2. Ireland Life Science 185 MSEK 3. Sweden Industrial & Engineering 55 MSEK 4. Netherlands Technology & Systems Solutions 35 MSEK Total 425 MSEK 8
Slide 9: Successful acquisition track record
Successful acquisition track record No. of acquired companies per year Quarterly financial effects acquisitions* 18 100 25% 16 90 14 80 20% 70 12 EBITA (MSEK) EBITA margin 60 15% 10 50 8 40 10% 6 30 4 20 5% 2 10 0 0 0% No. of acquired companies No. of acquired companies (3 yr avg) Acquired EBITA Acq
Slide 10: Key data summary
Key data summary MSEK 2025-Q2 2024-Q2 Change 2025-YTD 2024-YTD Change Order Intake 8,290 8,296 0% 16,752 16,333 3% Net Sales 8,121 8,491 -4% 16,157 16,235 0% Gross margin, % 35.3 35.4 35.3 35.2 EBITA 1,115 1,253 -11% 2,209 2,286 -3% EBITA-margin, % 13.7 14.8 13.7 14.1 Net financial items -116 -140 -
Slide 11: Cash Flow from operating activities
Cash Flow from operating activities Cash Flow development ▪ Operating cash flow during the quarter MSEK decreased to SEK 735 million (1,029), 1,800 160% driven by less favorable working capital 1,600 140% movements and the lower result. 1,400 1,200 120% ▪ Lower total organic working capital 100% 1,0
Slide 12: Earnings per share
Earnings per share EPS development ▪ EPS decreased 12% in the quarter to SEK SEK SEK 1.75 (2.00) per share. 2.5 9.0 8.0 ▪ 3- and 5-year rolling 4Q earnings per 2.0 7.0 share CAGR, were 4% and 12%. 6.0 1.5 5.0 4.0 1.0 3.0 0.5 2.0 1.0 0.0 0.0 2020 2021 2022 2023 2024 2025 Q EPS R12 EPS 12
Slide 13: Strong financial position
Strong financial position Net debt development ▪ The interest-bearing net debt MSEK increased since first quarter 2025 to 12,000 100% SEK 8,544 million (9,490), mainly due 90% 10,000 to dividend pay out. 80% 8,000 70% ▪ Net debt/equity ratio was 52% (63%). 60% ▪ Net debt/EBITDA was 1.5x (1.7x). 6,00
Slide 14: Key takeaways
Key takeaways ▪ Good underlying order intake – positive book-to- bill two quarters in a row. ▪ Lower sales and profit levels, impacted by lower backlog, fewer working days and challenging references. ▪ Expenses down vs Q1 – many companies continue Capital Markets Day to work actively with adapting c
Slide 15: Thank you!
Thank you! Indutrade
Slide 16: Financial calendar & contact details
Financial calendar & contact details Q3 Report Q4 Report Contact: ir@indutrade.com +46 8 703 03 00
Slide 17: Trusted by entrepreneurs
MT indutrade Trusted by entrepreneurs